+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Long-term outcome of kidney transplant patients with a positive serology for hepatitis C virus is similar to that of hepatitis C negative kidney transplant patients A collaborative study



Long-term outcome of kidney transplant patients with a positive serology for hepatitis C virus is similar to that of hepatitis C negative kidney transplant patients A collaborative study



Journal of the American Society of Nephrology 12(Program and Abstract Issue): 885A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035237207

Download citation: RISBibTeXText


Related references

Long-term outcomes and transmission rates in hepatitis C virus-positive donor to hepatitis C virus-negative kidney transplant recipients: Analysis of United States national data. Clinical Transplantation 31(10):, 2017

The relationship between serology of hepatitis E virus with liver and kidney function in kidney transplant patients. Excli Journal 15: 343-349, 2016

Long-term consequences of co-infection by hepatitis G virus in hepatitis c virus infected kidney transplant patients. Nephrologie 20(3): 165-170, 1999

Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection. Clinical Transplantation 9(2): 119-124, 1995

No evidence of occult hepatitis C virus (HCV) infection in serum of HCV antibody-positive HCV RNA-negative kidney-transplant patients. Transplant International 23(6): 594-601, 2010

Hepatitis B and hepatitis C virus infection and outcome of hemodialysis and kidney transplant patients. Renal Failure 30(1): 81-87, 2008

HBV DNA and other hepatitis B virus markers in sera from long-term hemodialysis and kidney transplant patients. Hepato-Gastroenterology 35(4): 147-150, 1988

Long term effect of hepatitis B and C virus infection on the survival of kidney transplant patients. Revista Da Associacao Medica Brasileira 49(4): 389-394, 2003

Outcomes of Hepatitis C-Positive Kidney Transplant Recipients Compared With Hepatitis C-Negative Recipients in Today's Era of Immunosuppression: A UNOS Database Analysis With Long-Term Follow-Up. Experimental and Clinical Transplantation 15(3): 282-288, 2017

Usefulness of liver biopsy in anti-hepatitis C virus antibody-positive and hepatitis C virus RNA-negative kidney transplant recipients. Transplantation 96(1): 85-90, 2013

Impact of donor hepatitis C virus infection status on death and need for liver transplant in hepatitis C virus-positive kidney transplant recipients. American Journal of Kidney Diseases 60(1): 112-120, 2012

Use of direct-acting agents for hepatitis C virus-positive kidney transplant candidates and kidney transplant recipients. Transplant International 29(12): 1257-1265, 2016

Long-term impact of superinfection by hepatitis G virus in hepatitis C virus-positive renal transplant patients. Transplantation 67(4): 556-560, 1999

Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors. Clinical Transplantation 20(3): 369-373, 2006

The Long-Term Effect of Hepatitis C Virus on the Outcome of Live-Donor Kidney Transplant Recipients. A Retrospective Study. Experimental and Clinical Transplantation 13(5): 402-407, 2015